Latest News Archive

Please select Category, Year, and then Month to display items

How British imperialism shaped South Africa’s education

02 September 2019 | Story Valentino Ndaba

Tracking how the government’s involvement in indigenous children’s education changed over time is the subject matter of Dr Rebecca Swartz’s new book, Education and Empire: Children, Race and Humanitarianism in the British Settler Colonies, 1833-1880. Dr Swartz, a Postdoctoral Research Fellow in the University of the Free State’s International Studies Group, published this monograph four years after completing her PhD.

As a historian of British imperialism in the 19th century and focusing on the intersections between childhood, race, and humanitarianism, Dr Swartz’s research is imperative in understanding the history of the South African education system. Her study draws on materials from the Caribbean and Australia, as well South African archives.

Education as a tool to carve equality
The book is a comparative study which addresses how the government, researchers, missionaries and members of the public viewed the function of education in the 19th-century British Empire. The book tackles a period during which changing conceptions of childhood, the functions of education, responsibilities of government, and the reach of governing indigenous peoples intersected.

Underlying the question of education’s function “were anxieties regarding the status of indigenous people in newly colonised territories: the successful education of their children could show their potential for equality”, says Dr Swartz. While the colonial government and missionaries often agreed that some education should be given to indigenous children, they wanted to use this to further their own aims which included religious conversion and creating a labour force. Indigenous parents and children themselves were rarely consulted on what they wanted from schooling.

Schools and race

According to the historical archives sifted through by Swartz, substantial data was gathered which point to the fact that schools played a major role in the production and reproduction of racial differences in the colonies of settlement.

A shift in thinking took place between 1833 and 1880, both in Britain and the Empire. Education was increasingly seen as a government responsibility. With this new outlook childhood was approached as a time to make interventions into indigenous people’s lives. “This period also saw shifts in thinking about race,” says Dr Swartz. Remnants of that thinking can be seen in present-day South Africa.

Considering the bigger picture

When Dr Swartz began her research at the University of London in 2012, her main focus was to provide a broader understanding which transcended histories of either the development of ‘white’ schooling for settler children or Marxist histories of education of the apartheid period. “I was interested in finding out more about education for indigenous children during the 19th century, often in the early years of colonial settlement, an area that had received fairly little attention in the literature.”

Interested in a copy of the book?
Click here for a discount flyer for the book. Copies are also available on Amazon.

News Archive

Cardiology Unit involved in evaluation of drug for rare genetic disease

2013-01-04

Front from the left, are: Marinda Karsten (study coordinator and registered nurse),
Laumarie de Wet (clinical technologist), Charmaine Krahenbuhl (study coordinator and radiographer),
Lorinda de Meyer (administrator), Andonia Page (study coordinator and enrolled nurse);
back Dr Gideon Visagie (sub investigator), Dr Derick Aucamp (sub investigagtor),
Prof. Hennie Theron, (principal investigator) and Dr Wilhelm Herbst (sub investigator).
Photo: Supplied
09 January 2013

The Cardiology Research Unit at the University of the Free State (UFS) contributed largely to the evaluation of the drug Juxtapid (lomitapide), which was developed by the Aegerion pharmaceutical company and approved by the FDA (Federal Drug Administration). Together with countries such as die USA, Canada and Italy, the UFS’ Unit recruited and evaluated the most patients (5 of 29) for the study since 2008.

The drug was evaluated in persons with so-called familial homozygous hypercholesterolemia (HoFH).

Following its approval by the FDA, Juxtapid is now a new treatment option for patients suffering from HoFH. The drug operates in a unique way which brings about dramatic improvements in cholesterol counts.

According to Prof. Hennie Theron, Associate Professor in the Department of Cardiology at the UFS and Head of the Cardiology Contract Research Unit, HoFH is a serious, rare genetic disease which affects the function of the receptor responsible for the removal of low-density lipoprotein cholesterol (LDL-C) (“bad” cholesterol) from the body. Damage to the LDL receptor function leads to extremely high levels of blood cholesterol. HoFH patients often develop premature and progressive atherosclerosis, which is a narrowing or blockage of the arteries.

“HoFH is a genetically transmitted disease and the most severe form of hypercholesterolemia. Patients often need a coronary artery bypass or/and aortic valve replacement before the age of 20. Mortality is extremely high and death often occurs before the third decade of life. Existing conventional cholesterol-lowering medication is unsuccessful in achieving normal target cholesterol values in this group of patients.

“The only modality for treatment is plasmapheresis (similar to dialysis in patients with renal failure). Even with this type of therapy the results are relatively unsatisfactory because it is very expensive and the plasmapheresis has to be performed on a regular basis.

“The drug Juxtapid, as currently evaluated, has led to a dramatic reduction in cholesterol values and normal values were achieved in several people. No existing drug is nearly as effective.

“The drug represents a breakthrough in the treatment of familial homozygous hypercholesterolemia. The fact that it has been approved by the FDA, gives further impetus to the findings,” says Prof. Theron.

In future further evaluation will be performed in other forms of hypocholesterolemia.

According to Prof. Theron, the findings of the study, as well as the recent successful FDA evaluation, once again confirms the fact that the UFS’ Cardiology Contract Research Unit is doing outstanding work.

Since its inception in 1992, the Unit has already been involved in more than 60 multi-centre, international phase 2 and 3 drug studies. Several of these studies, including the abovementioned study, really affected the way in which cardiology functions.

The UFS’ Cardiology Contract Research Unit is being recognised nationally and internationally for its high quality of work and is constantly approached for their involvement in new studies.

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept